|
CONDENSED FINANCIAL STATEMENTS
|
6 Months Ended |
|---|---|
|
Mar. 31, 2015
|
|
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| CONDENSED FINANCIAL STATEMENTS |
NOTE 1 CONDENSED FINANCIAL STATEMENTS
The accompanying consolidated financial statements have been prepared by Ohr Pharmaceutical, Inc. (the Company) without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at March 31, 2015, and for all periods presented herein, have been made.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Companys September 30, 2014 audited consolidated financial statements. The results of operations for the periods ended March 31, 2015 and 2014 are not necessarily indicative of the operating results for the full years. |